サンプル依頼リスト カート
  • English
  • Korean
表紙：呼吸器疾患用ワクチンの世界市場規模調査＆予測、タイプ別、年齢層別、感染症別、流通チャネル別、地域別分析、2023～2030年
市場調査レポート
商品コード
1381652

呼吸器疾患用ワクチンの世界市場規模調査＆予測、タイプ別、年齢層別、感染症別、流通チャネル別、地域別分析、2023～2030年

Global Respiratory Disease Vaccine Market Size study & Forecast, by Type by Age Group, by Infection (COVID-19, Influenza, Respiratory Syncytial Virus, Pneumonia, Others), by Distribution Channel and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
呼吸器疾患用ワクチンの世界市場規模調査＆予測、タイプ別、年齢層別、感染症別、流通チャネル別、地域別分析、2023～2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

呼吸器疾患用ワクチンの世界市場は、2022年に約922億3,000万米ドルと評価され、予測期間2023～2030年には1.21％以上の健全な成長率で成長すると予測されています。

呼吸器疾患は、呼吸に関わる器官を含む呼吸器系に影響を及ぼします。呼吸器系は、酸素の摂取と二酸化炭素の体外排出を担っています。様々な条件が呼吸器系の正常な機能を乱し、呼吸器疾患を引き起こします。呼吸器疾患用ワクチン市場は、呼吸器疾患の有病率の上昇やワクチン開発のための研究開発活動の活発化などの要因により拡大しています。

喘息、肺炎、結核など様々な呼吸器疾患の有病率の上昇が市場成長の原動力となっています。例えば、世界保健機関（WHO）の「Global Tuberculosis Report 2021」によると、2021年10月、結核患者の多くは東南アジア（43％）、アフリカ（25％）、西太平洋（18％）で発見され、東地中海（8.3％）、欧州（2.3％）で発見されたケースは少なかっています。さらに、世界保健機関（WHO）が発表した統計によると、2020年には世界で約1,000万人が結核に罹患し、2021年10月には約150万人が結核が原因で死亡しています。また、2015年のStatistaによると、インド全土の高齢者の喘息患者数は900万人で、2020年には1,070万人に増加し、2050年には2,540万人に達すると予測されています。このように、成長全体における呼吸器疾患の有病率の上昇が市場成長の原動力となっています。また、ワクチン開発活動に対する政府支援の増加や啓発プログラムの増加が、市場成長に有利な機会をもたらしています。しかし、呼吸器疾患用ワクチンの研究開発には高いコストがかかるため、2023～2030年の予測期間を通じて市場成長の足かせとなっています。

呼吸器疾患用ワクチンの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、ワクチン開発のための高度な医療技術の利用可能性、研究開発プログラムの増加、公開会社および非公開会社による投資の増加、医療支出の増加により、2022年の市場を独占しました。一方、アジア太平洋は、対象となる疾患の有病率の上昇、医療支出の増加、同地域におけるワクチン開発促進のための政府イニシアチブの高まりなどの要因により、大きな成長を記録すると予測されています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 呼吸器疾患用ワクチンの世界市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 呼吸器疾患用ワクチンの世界市場力学

  • 呼吸器疾患用ワクチン市場の影響分析（2020～2030年）
    • 市場促進要因
      • 呼吸器疾患の有病率の上昇
      • ワクチン開発のための研究開発活動の増加
    • 市場の課題
      • 呼吸器疾患用ワクチン開発の初期コストの高さ
    • 市場機会
      • ワクチン開発活動に対する政府支援の増加
      • 疾患啓発プログラムの増加

第4章 呼吸器疾患用ワクチンの世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 呼吸器疾患用ワクチンの世界市場：タイプ別

  • 市場スナップショット
  • 呼吸器疾患用ワクチンの世界市場：タイプ別、実績・ポテンシャル分析
  • 呼吸器疾患用ワクチンの世界市場：タイプ別、推定・予測、2020～2030年
  • 呼吸器疾患用ワクチン市場、サブセグメント別分析
    • ウイルスワクチン
    • 細菌ワクチン
    • 混合ワクチン

第6章 呼吸器疾患用ワクチンの世界市場：年齢層別

  • 市場スナップショット
  • 呼吸器疾患用ワクチンの世界市場：年齢層別、実績・ポテンシャル分析
  • 呼吸器疾患用ワクチンの世界市場：年齢層別、推定・予測、2020～2030年
  • 呼吸器疾患用ワクチン市場、サブセグメント分析
    • 小児
    • 成人

第7章 呼吸器疾患用ワクチンの世界市場：感染症別

  • 市場スナップショット
  • 呼吸器疾患用ワクチンの世界市場：感染症別、実績・ポテンシャル分析
  • 呼吸器疾患用ワクチンの世界市場：感染症別、推定・予測、2020～2030年
  • 呼吸器疾患用ワクチン市場、サブセグメント別分析
    • COVID-19
    • インフルエンザ
    • 呼吸器合胞体ウイルス（RSV）
    • 肺炎
    • その他

第8章 呼吸器疾患用ワクチンの世界市場：流通チャネル別

  • 市場スナップショット
  • 呼吸器疾患用ワクチンの世界市場：流通チャネル別、実績・ポテンシャル分析
  • 呼吸器疾患用ワクチンの世界市場：流通チャネル別、推定・予測、2020～2030年
  • 呼吸器疾患用ワクチン市場、サブセグメント別分析
    • 病院・小売薬局
    • 政府系サプライヤー
    • その他

第9章 呼吸器疾患用ワクチンの世界市場：地域別分析

  • 主要国
  • 主な新興国
  • 呼吸器疾患用ワクチン市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別、推定・予測、2020～2030年
      • 年齢層別、推定・予測、2020～2030年
      • 感染症別、推定・予測、2020～2030年
      • 流通チャネル別、推定・予測、2020～2030年
    • カナダ
  • 欧州の呼吸器疾患用ワクチン市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋の呼吸器疾患用ワクチン市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカの呼吸器疾患用ワクチン市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東およびアフリカ

第10章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • GSK plc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • Johnson & Johnson Services, Inc.
    • Pfizer Inc.
    • Sanofi-Aventis
    • Serum Institute of India Pvt. Ltd.
    • Sinovac Biotech Ltd
    • Bavarian Nordic A/S
    • Merck & Co., Inc.
    • AstraZeneca plc
    • Emergent BioSolutions Inc

第11章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Respiratory Disease Vaccine Market, report scope
  • TABLE 2. Global Respiratory Disease Vaccine Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Respiratory Disease Vaccine Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Respiratory Disease Vaccine Market estimates & forecasts by Age Group 2020-2030 (USD Billion)
  • TABLE 5. Global Respiratory Disease Vaccine Market estimates & forecasts by Infection 2020-2030 (USD Billion)
  • TABLE 6. Global Respiratory Disease Vaccine Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 7. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Respiratory Disease Vaccine Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. Global Respiratory Disease Vaccine Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 18. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. U.S. Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 20. Canada Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 21. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. Canada Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 23. UK Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 24. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. UK Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 26. Germany Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 27. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. Germany Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 29. France Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 30. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. France Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 32. Italy Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 33. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Italy Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 35. Spain Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 36. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. Spain Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 38. RoE Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 39. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. RoE Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 41. China Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 42. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. China Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 44. India Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 45. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. India Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 47. Japan Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 48. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. Japan Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 50. South Korea Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 51. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. South Korea Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 53. Australia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 54. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. Australia Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. RoAPAC Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 59. Brazil Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 60. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Brazil Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 62. Mexico Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 63. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. Mexico Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 65. RoLA Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 66. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. RoLA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 68. Saudi Arabia Respiratory Disease Vaccine Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 69. South Africa Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. RoMEA Respiratory Disease Vaccine Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 71. List of secondary sources, used in the study of global Respiratory Disease Vaccine Market
  • TABLE 72. List of primary sources, used in the study of global Respiratory Disease Vaccine Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Respiratory Disease Vaccine Market, research methodology
  • FIG 2. Global Respiratory Disease Vaccine Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Respiratory Disease Vaccine Market, key trends 2022
  • FIG 5. Global Respiratory Disease Vaccine Market, growth prospects 2023-2030
  • FIG 6. Global Respiratory Disease Vaccine Market, porters 5 force model
  • FIG 7. Global Respiratory Disease Vaccine Market, pest analysis
  • FIG 8. Global Respiratory Disease Vaccine Market, value chain analysis
  • FIG 9. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Respiratory Disease Vaccine Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Respiratory Disease Vaccine Market, regional snapshot 2020 & 2030
  • FIG 15. North America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Respiratory Disease Vaccine Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Respiratory Disease Vaccine Market is valued approximately USD 92.23 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.21% over the forecast period 2023-2030. Respiratory diseases affect the respiratory system, which includes the organs involved in breathing. The respiratory system is responsible for the intake of oxygen and the elimination of carbon dioxide from the body. Various conditions can disrupt the normal functioning of the respiratory system, leading to respiratory diseases. The Respiratory Disease Vaccine market is expanding because of factors such as the rising prevalence of respiratory disorders and increasing research and development activities for vaccine development.

The rising prevalence of various respiratory diseases such as Asthma, Pneumonia, Tuberculosis, and more is driving the market growth. For instance, the World Health Organization's (WHO) Global Tuberculosis Report 2021 states that in October 2021, most tuberculosis cases were discovered in South-East Asia (43%), Africa (25%), and the Western Pacific (18%), while fewer cases were discovered in the Eastern Mediterranean (8.3%), and Europe (2.3%). Additionally, according to statistics released by the World Health Organization (WHO), around 10 million individuals worldwide contracted tuberculosis in 2020, and roughly 1.5 million people died as a result of the disease in October 2021. Moreover, according to Statista in the year 2015, the Number of cases of asthma in senior citizens across India stood at 9 million which increased to 10.7 million in the year 2020, and it is projected to reach 25.4 million by the year 2050. Thus, the rising prevalence of respiratory diseases across the growth is driving the market growth. In addition, increasing government support for vaccine development activities and a rising number of awareness programs is creating a lucrative opportunity to market growth. However, the high cost involved with research and development of respiratory disease vaccines stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Respiratory Disease Vaccine Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the availability of advanced healthcare technologies for vaccine development, rising number of research and development programs, rising investment by public and private companies, and rising healthcare expenditure. Whereas, Asia Pacific is projected to register significant growth owing to factors such as the rising prevalence of targeted diseases, rising healthcare expenditure, and rising government initiatives to promote vaccine development in the region.

Major market player included in this report are:

  • GSK plc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Sanofi- Aventis
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech Ltd
  • Bavarian Nordic A/S
  • Merck & Co., Inc.
  • AstraZeneca plc
  • Emergent BioSolutions Inc

Recent Developments in the Market:

  • In February 2022, Moderna, Inc. declared plans to expand its footprint in the region by creating new companies in Taiwan, Malaysia, Singapore, Hong Kong, and Taiwan in order to scale up the manufacture and distribution of mRNA and the COVID-9 vaccine.
  • In May 2023, The US Food and Drug Administration (FDA) approved Arexvy (the respiratory syncytial virus vaccine, adjuvanted) for use in people 60 years of age and older to prevent lower respiratory tract disease (LRTD) brought on by the respiratory syncytial virus (RSV).

Global Respiratory Disease Vaccine Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Type, Age Group, Infection, Distribution Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Viral Vaccine
  • Bacterial Vaccine
  • Combination Vaccine

By Age Group:

  • Pediatric
  • Adult

By Infection:

  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Pneumonia
  • Others

By Distribution Channel:

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Respiratory Disease Vaccine Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Respiratory Disease Vaccine Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Respiratory Disease Vaccine Market, by Age Group, 2020-2030 (USD Billion)
    • 1.2.4. Respiratory Disease Vaccine Market, by Infection, 2020-2030 (USD Billion)
    • 1.2.5. Respiratory Disease Vaccine Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Respiratory Disease Vaccine Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Respiratory Disease Vaccine Market Dynamics

  • 3.1. Respiratory Disease Vaccine Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Rising prevalence of respiratory disorders
      • 3.1.1.2. Increasing research and development activities for vaccine development
    • 3.1.2. Market Challenges
      • 3.1.2.1. High initial cost of respiratory disease vaccine development
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increasing government support for the vaccine development activities
      • 3.1.3.2. Rising number of disease awareness programs

Chapter 4. Global Respiratory Disease Vaccine Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Respiratory Disease Vaccine Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Respiratory Disease Vaccine Market by Type, Performance - Potential Analysis
  • 5.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
    • 5.4.1. Viral Vaccine
    • 5.4.2. Bacterial Vaccine
    • 5.4.3. Combination Vaccine

Chapter 6. Global Respiratory Disease Vaccine Market, by Age Group

  • 6.1. Market Snapshot
  • 6.2. Global Respiratory Disease Vaccine Market by Age Group, Performance - Potential Analysis
  • 6.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Age Group 2020-2030 (USD Billion)
  • 6.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
    • 6.4.1. Pediatric
    • 6.4.2. Adult

Chapter 7. Global Respiratory Disease Vaccine Market, by Infection

  • 7.1. Market Snapshot
  • 7.2. Global Respiratory Disease Vaccine Market by Infection, Performance - Potential Analysis
  • 7.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Infection 2020-2030 (USD Billion)
  • 7.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
    • 7.4.1. COVID-19
    • 7.4.2. Influenza
    • 7.4.3. Respiratory Syncytial Virus (RSV)
    • 7.4.4. Pneumonia
    • 7.4.5. Others

Chapter 8. Global Respiratory Disease Vaccine Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Respiratory Disease Vaccine Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Respiratory Disease Vaccine Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 8.4. Respiratory Disease Vaccine Market, Sub Segment Analysis
    • 8.4.1. Hospital & Retail Pharmacies
    • 8.4.2. Government Suppliers
    • 8.4.3. Others

Chapter 9. Global Respiratory Disease Vaccine Market, Regional Analysis

  • 9.1. Top Leading Countries
  • 9.2. Top Emerging Countries
  • 9.3. Respiratory Disease Vaccine Market, Regional Market Snapshot
  • 9.4. North America Respiratory Disease Vaccine Market
    • 9.4.1. U.S. Respiratory Disease Vaccine Market
      • 9.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 9.4.1.2. Age Group breakdown estimates & forecasts, 2020-2030
      • 9.4.1.3. Infection breakdown estimates & forecasts, 2020-2030
      • 9.4.1.4. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 9.4.2. Canada Respiratory Disease Vaccine Market
  • 9.5. Europe Respiratory Disease Vaccine Market Snapshot
    • 9.5.1. U.K. Respiratory Disease Vaccine Market
    • 9.5.2. Germany Respiratory Disease Vaccine Market
    • 9.5.3. France Respiratory Disease Vaccine Market
    • 9.5.4. Spain Respiratory Disease Vaccine Market
    • 9.5.5. Italy Respiratory Disease Vaccine Market
    • 9.5.6. Rest of Europe Respiratory Disease Vaccine Market
  • 9.6. Asia-Pacific Respiratory Disease Vaccine Market Snapshot
    • 9.6.1. China Respiratory Disease Vaccine Market
    • 9.6.2. India Respiratory Disease Vaccine Market
    • 9.6.3. Japan Respiratory Disease Vaccine Market
    • 9.6.4. Australia Respiratory Disease Vaccine Market
    • 9.6.5. South Korea Respiratory Disease Vaccine Market
    • 9.6.6. Rest of Asia Pacific Respiratory Disease Vaccine Market
  • 9.7. Latin America Respiratory Disease Vaccine Market Snapshot
    • 9.7.1. Brazil Respiratory Disease Vaccine Market
    • 9.7.2. Mexico Respiratory Disease Vaccine Market
  • 9.8. Middle East & Africa Respiratory Disease Vaccine Market
    • 9.8.1. Saudi Arabia Respiratory Disease Vaccine Market
    • 9.8.2. South Africa Respiratory Disease Vaccine Market
    • 9.8.3. Rest of Middle East & Africa Respiratory Disease Vaccine Market

Chapter 10. Competitive Intelligence

  • 10.1. Key Company SWOT Analysis
    • 10.1.1. Company 1
    • 10.1.2. Company 2
    • 10.1.3. Company 3
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. GSK plc.
      • 10.3.1.1. Key Information
      • 10.3.1.2. Overview
      • 10.3.1.3. Financial (Subject to Data Availability)
      • 10.3.1.4. Product Summary
      • 10.3.1.5. Recent Developments
    • 10.3.2. Johnson & Johnson Services, Inc.
    • 10.3.3. Pfizer Inc.
    • 10.3.4. Sanofi- Aventis
    • 10.3.5. Serum Institute of India Pvt. Ltd.
    • 10.3.6. Sinovac Biotech Ltd
    • 10.3.7. Bavarian Nordic A/S
    • 10.3.8. Merck & Co., Inc.
    • 10.3.9. AstraZeneca plc
    • 10.3.10. Emergent BioSolutions Inc

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption